Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Plus Therapeutics, Inc. (PSTV) had Debt to Equity Ratio of 0.19 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$5.21M |
|
$-22.39M |
|
-- |
|
$5.21M |
|
$20.51M |
|
$-15.30M |
|
$-7.09M |
|
$-22.39M |
|
$-22.39M |
|
$-22.39M |
|
$-22.39M |
|
$-22.39M |
|
$-22.39M |
|
$-15.30M |
|
$-14.85M |
|
3.11M |
|
3.11M |
|
$-7.25 |
|
$-7.25 |
|
| Balance Sheet Financials | |
$15.17M |
|
$0.26M |
|
$1.16M |
|
$16.32M |
|
$12.31M |
|
-- |
|
$0.01M |
|
$12.33M |
|
$4.00M |
|
$3.29M |
|
$4.00M |
|
5.55M |
|
| Cash Flow Statement Financials | |
$-20.77M |
|
$-0.85M |
|
$30.31M |
|
$0.08M |
|
$8.76M |
|
$8.68M |
|
$1.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.23 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.19 |
100.00% |
|
-293.46% |
|
-293.46% |
|
-284.92% |
|
-429.43% |
|
-429.43% |
|
$-20.81M |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
-- |
|
16.19 |
|
22.55 |
|
-560.21% |
|
-680.22% |
|
-137.13% |
|
-560.21% |
|
$0.72 |
|
$-6.69 |
|
$-6.68 |
|